Global infantile spasms therapeutics market 2017 2021
1. “Global Infantile Spasms Therapeutics Market 2017-2021”
just published: MarketResearchReports.Biz
MarketResearchReports.Biz has announced addition of new report “Global Infantile Spasms
Therapeutics Market 2017-2021” to its database.
An infantile spasm is a particular type of seizure found in an epilepsy syndrome of infancy and childhood. It is
also known as a West syndrome. The onset of infantile spasm is usually found in the first year of life between
four months and eight months of age. The condition constitutes 2% of childhood epilepsies and 25% of
epilepsies with onset in the first year of life. There are around 2,000-4,000 new cases observed in the US each
year. The overall long-term prognosis for infantile spasms patients is poor. It has been found that 50%-70% of
infantile spasms patients develop other seizure types and 18%-50% will develop LennoxGastaut syndrome
(LGS) or other forms of symptomatic generalized epilepsy.
Technavios analysts forecast the global infantile spasms therapuetics market to grow at a CAGR of 10.16%
during the period 2017-2021.
Click here to know more details about this report:
http://www.marketresearchreports.biz/analysis/915036
Covered in this report
The report covers the present scenario and the growth prospects of the global thoracic surgery market for
2017-2021. To calculate the market size, the report considers the revenue generated from the sales of infantile
spasms therapuetics.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Infantile Spasms Therapeutics Market 2017-2021, has been prepared based on an
in-depth market analysis with inputs from industry experts. The report covers the market landscape and its
growth prospects over the coming years. The report also includes a discussion of the key vendors operating in
this market.
2. Key vendors
• H. Lundbeck
• Mallinckrodt Pharmaceuticals
• INSYS Therapeutics
Other prominent vendors
• Anavex Life Sciences
• Catalyst Pharmaceuticals
• GW Pharmaceuticals
• ORPHELIA Pharma
• Retrophin
• Valerion Therapeutics
Market driver
Major drugs launch expected in 2017-2021
For a full, detailed list, view our report
Market challenge
Growing usage of seizure management devices, a threat to drug therapies
For a full, detailed list, view our report
Market trend
Development of devices and smartphone apps to detect seizures and track medications
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
3. You can request one free hour of our analysts time when you purchase this market report. Details are provided
within the report.
Request a sample copy of this report:
http://www.marketresearchreports.biz/sample/sample/915036
About Us
MarketResearchReports.biz is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a
one stop solution for all your research needs, our main offerings are syndicated research reports, custom
research, subscription access and consulting services. We serve all sizes and types of companies spanning
across various industries.
Browse Latest Industry Press Release http://www.marketresearchreports.biz/pressreleases
Contact Us
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
Email: sales@marketresearchreports.biz
Follow us on LinkedIn: https://www.linkedin.com/company/marketresearchreports-biz